IOVA Iovance Biotherapeutics, Inc.: Prakiraan rega marang bathi

IOVA (Iovance Biotherapeutics) - tandha merek perusahaan

Iovance Biotherapeutics focuses on independent product launches, limiting partnerships strictly to joint testing. The company's forward P/E valuation shows local growth, with the metric recorded at 0.00. Breakthrough treatments for solid tumors using the patient's own cells are combined with strict adherence to bioethics and the minimization of the carbon footprint during drug production.

iovance.com - Pangali mangsa ngarep rega marang bathi IOVA (periode 04.07.2022 - 15.11.2026)

Rincian metrik lan analitis perusahaan iovance.com (IOVA)

Analisis fundamental perusahaan:Iovance Biotherapeutics Inc IOVA
Produk mawa merek Iovance Biotherapeutics

Investors utilize multiples to verify the fair value of assets and assess risks. The forward P/E ratio of the company reflects the relationship between the market price and expected net income, allowing for the discounting of future cash flows. This chart captures shifts in market consensus between quarterly reports. For Iovance Biotherapeutics (IOVA), this indicator measures the market's willingness to pay for the commercialization of TIL therapy and insurance company reimbursements. A decline in this ratio alongside earnings growth confirms the fundamental resilience of the business.

Analisis perusahaan pesaing

Pangali Forward P/E IBRX|Immunocore Holdings plc (IMCR) - Pangali forward rega marang bathi|Janux Therapeutics Inc - Prakiraan rega marang bathi|Arcus Biosciences (RCUS) - Rasio prakiraan rega marang bathi|ZYME: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TNGX (Tango Therapeutics, Inc.)|IMTX: Pangali Forward P/E|XNCR - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep compasstherapeutics.com|Prakiraan rega marang bathi replimune.com (REPL)|Rega marang bathi mangsa ngarep Lyell (LYEL)|Prakiraan rega marang bathi Innate Pharma, S.A. IPHA|Pyxis Oncology Inc. - Prakiraan rega marang bathi|Pangali Forward P/E Compugen Ltd. CGEN|IOBT - Rega marang bathi mangsa ngarep|STRO (sutrobio.com) - Rasio rega marang bathi mangsa ngarep|MiNK Therapeutics, Inc (INKT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Werewolf Therapeutics (HOWL)|Prakiraan rega marang bathi IMMX|ALXO - Pangali forward rega marang bathi|Pangali Forward P/E CUE|Rasio kapitalisasi marang bathi mangsa ngarep PDSB|Pangali Forward P/E SONN (Sonnet BioTherapeutics)|Pangali mangsa ngarep rega marang bathi MAIA|liminatuspharma.com - Pangali Forward P/E|Rasio prakiraan rega marang bathi LAVA Therapeutics|NextCure, Inc. (NXTC) - Rega marang bathi mangsa ngarep|Leap Therapeutics Inc - Pangali mangsa ngarep rega marang bathi|INTS (Intensity Tx) - Pangali Forward P/E|Pangali Forward P/E senseibio.com|Rega marang bathi mangsa ngarep Theriva Biologics (TOVX)|GRTS: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E KA (kinetabio.com)|neximmune.com (NEXI) - Rasio prakiraan rega marang bathi|TSBX: Prakiraan rega marang bathi|VCNX: Rega marang bathi mangsa ngarep|HARP: Pangali Forward P/E